Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 18, 2022
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
[ Thu, Aug 18th 2022
] - WOPRAI
Matthew Sykes Downgraded (TXG) to Strong Sell and Decreased Target to $35 on, Aug 18th, 2022
Matthew Sykes of Goldman Sachs, Downgraded "10x Genomics, Inc." (TXG) to Strong Sell and Decreased Target from $55 to $35 on, Aug 18th, 2022.
Matthew has made no other calls on TXG in the last 4 months.
There are 6 other peers that have a rating on TXG. Out of the 6 peers that are also analyzing TXG, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Weinstein of "William Blair" Downgraded from Buy to Hold on, Friday, July 15th, 2022
- Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $60 on, Thursday, July 14th, 2022
These are the ratings of the 4 analyists that currently disagree with Matthew
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $70 on, Wednesday, August 10th, 2022
- Dan Brennan of "Cowen & Co." Maintained at Buy with Decreased Target to $50 on, Friday, July 15th, 2022
- Derik De Bruin of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $35 on, Friday, July 15th, 2022
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, May 5th, 2022
